Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

Genetic predisposition to hyperhomocysteinemia: deficiency of methylenetetrahydrofolate reductase (MTHFR).

Rozen R.

Thromb Haemost. 1997 Jul;78(1):523-6. Review. No abstract available.

PMID:
9198208
2.

[Role of polymorphic variants of the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene in the pathogenesis of cardiovascular diseases].

Spiridonova MG, Stepanov VA, Puzyrev VP.

Klin Med (Mosk). 2001;79(2):10-6. Review. Russian. No abstract available.

PMID:
11419077
4.

Hyperhomocysteinemia, MTHFR, and risk of vascular disease.

Blom HJ, Verhoef DP.

Circulation. 2000 Apr 25;101(16):E171; author reply E173. No abstract available.

5.

MTHFR gene polymorphism, homocysteine and cardiovascular disease.

Cortese C, Motti C.

Public Health Nutr. 2001 Apr;4(2B):493-7. Review.

PMID:
11683544
6.

Methylenetetrahydrofolate reductase gene and coronary artery disease.

Mager A.

Circulation. 2000 Apr 25;101(16):E172-3. No abstract available.

7.

Homocysteine and cardiovascular risk.

Scott JM.

Am J Clin Nutr. 2000 Aug;72(2):333-4. No abstract available.

8.

Recent data are not in conflict with homocysteine as a cardiovascular risk factor.

Refsum H, Ueland PM.

Curr Opin Lipidol. 1998 Dec;9(6):533-9. Review.

PMID:
9868588
9.

Folate, homocysteine, endothelial function and cardiovascular disease. What is the link?

Ashfield-Watt PA, Moat SJ, Doshi SN, McDowell IF.

Biomed Pharmacother. 2001 Oct;55(8):425-33. Review.

PMID:
11686575
10.
11.

Hyperhomocysteinemia: another independent vascular risk factor.

Deleu D.

Saudi Med J. 2000 Aug;21(8):787-8. No abstract available.

PMID:
11423902
12.

Thermolabile methylenetetrahydrofolate reductase, homocysteine, and cardiovascular disease risk: the European Concerted Action Project.

Meleady R, Ueland PM, Blom H, Whitehead AS, Refsum H, Daly LE, Vollset SE, Donohue C, Giesendorf B, Graham IM, Ulvik A, Zhang Y, Bjorke Monsen AL; EC Concerted Action Project: Homocysteine and Vascular Disease..

Am J Clin Nutr. 2003 Jan;77(1):63-70.

13.

Homocysteine screening of a female Hispanic population.

Wu AH, Holtman V, Tsongalis GJ, Macer J.

Int J Mol Med. 1999 Sep;4(3):295-7.

PMID:
10425282
14.
15.

Interplay between methylenetetrahydrofolate reductase gene polymorphism 677C-->T and serum folate levels in determining hyperhomocysteinemia in heart transplant recipients.

Potena L, Grigioni F, Viggiani M, Magnani G, Sorbello S, Falchetti E, Sassi S, Mantovani V, Bacchi-Reggiani L, Magelli C, Branzi A.

J Heart Lung Transplant. 2001 Dec;20(12):1245-51.

PMID:
11744407
16.

The effect of methylenetetrahydrofolate reductase C677T common variant on hypertensive risk is not solely explained by increased plasma homocysteine values.

Rodríguez-Esparragón F, Hernández-Perera O, Rodríguez-Pérez JC, Anábitarte A, Díaz-Cremades JM, Losada A, Fiuza D, Hernández E, Yunis C, Ferrario CM.

Clin Exp Hypertens. 2003 May;25(4):209-20.

PMID:
12797595
17.

[Hyperhomocysteinemia: an independent risk factor or a simple marker of vascular disease?. 1. Basic data].

Guilland JC, Favier A, Potier de Courcy G, Galan P, Hercberg S.

Pathol Biol (Paris). 2003 Mar;51(2):101-10. Review. French.

PMID:
12801808
18.

Premature arterial and venous events in three families. Effect of folate levels and MTHFR mutation mediated by family/generation and homocysteine levels.

Assanelli D, Grassi M, Bonanome A, Salvadori G, Bonetti P, Boldini A, Archetti S, Ruggeri G, Pezzini A, Pagnan A.

Thromb Res. 2002 Jan 15;105(2):109-15.

PMID:
11958800
19.

[Familial predisposition to ischemic cardiopathy: role of homocysteine and genetic polymorphism of methylenetetrahydrofolate reductase].

Potena L, Grigioni F, Mantovani V, Magnani G, Magelli C, Branzi A.

Ital Heart J Suppl. 2001 Jul;2(7):748-53. Review. Italian.

PMID:
11508292
20.

Frequency of factor V (FV) Leiden and C677T methylenetetrahydrofolate reductase (MTHFR) mutations in Colombians.

Camacho Vanegas O, Giusti B, Restrepo Fernandez CM, Abbate R, Pepe G.

Thromb Haemost. 1998 Apr;79(4):883-4. No abstract available.

PMID:
9569213

Supplemental Content

Support Center